Jazz leaps into epilepsy with $7.2B buyout of cannabinoid drugmaker GW Pharma fkansteiner Wed, 02/03/2021 – 11:28 More: Jazz leaps into epilepsy with .2B buyout of cannabinoid drugmaker GW Pharma Source: fierce
read moreAbbVie’s immunology newbies Skyrizi and Rinvoq pick up the slack from declining Humira, but safety questions dog execs arlene.weintraub Wed, 02/03/2021 – 11:19 More: AbbVie's immunology newbies Skyrizi and Rinvoq pick up the slack from declining Humira, but safety questions
read moreBiogen’s sales slide on Spinraza, Tecfidera as pivotal Alzheimer’s decision nears esagonowsky Wed, 02/03/2021 – 10:28 More: Biogen's sales slide on Spinraza, Tecfidera as pivotal Alzheimer's decision nears Source: fierce
read moreThe drug met both co-primary endpoints compared to placebo in the trial More: BMS’ deucravacitinib beats Otezla in psoriasis study Source: News
read moreAmid supply snafu, new data show AstraZeneca’s COVID-19 shot is more effective with doses 12 weeks apart esagonowsky Tue, 02/02/2021 – 14:08 More: Amid supply snafu, new data show AstraZeneca's COVID-19 shot is more effective with doses 12 weeks apart
read moreBristol Myers offloading Swiss tablet and capsule plant to Chinese CDMO WuXi STA fkansteiner Tue, 02/02/2021 – 13:28 More: Bristol Myers offloading Swiss tablet and capsule plant to Chinese CDMO WuXi STA Source: fierce
read more© 1994 - 2026 B.M. Pharmaceuticals